节点文献

甲状腺激素联合B型脑钠肽检测对急性心力衰竭患者预后的影响

Prognosis value of thyroxin with B-type natriuretic peptide for patients with acute heart failure

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 全军民姚琪陶袁邱樑周林丽陈浩俞林吕峰曲迪潘金安

【Author】 QUAN Junmin;YAO Qi;TAO Yuan;Department of Cardiology, Shengzhou People’s Hospital, the First Affiliated Hospital of Zhejiang University Shengzhou Branch;

【机构】 嵊州市人民医院(浙大一院嵊州分院)心内科

【摘要】 目的探讨甲状腺激素联合B型脑钠肽(BNP)检测对急性心力衰竭(AHF)患者预后的影响。方法纳入AHF患者619例,入院后测定甲状腺激素、BNP。根据患者随访结果分为死亡组和生存组。应用Cox风险模型、ROC曲线和Kaplan-Meier生存曲线分析甲状腺激素和BNP与全因死亡的关系。结果低T3综合征(LT3S)发生率为44.4%。在(19±13)个月随访期间,死亡204例(32.9%)。Cox风险模型分析显示年龄(HR=1.033,95%CI:1.017~1.049,P<0.01),游离三碘甲状腺原氨酸(FT3)(HR=0.489,95%CI:0.384~0.628,P<0.01)、BNP(HR=2.136,95%CI:1.114~4.126,P<0.01)和肌酐(HR=1.002,95%CI:1.001~1.003,P<0.05)是全因死亡的独立危险因素。根据FT3(≤2.72pmol/L)和BNP(>2 230pg/ml)的切点,Kaplan-Meier生存曲线分析显示低FT3(≤2.72 pmol/L)/高BNP(>2 230pg/ml)组患者全因死亡风险最高(HR=7.247,95%CI:3.993~13.152,P<0.01)。结论 FT3是AHF患者全因死亡的独立危险因素,低FT3/高BNP患者远期预后更差。

【Abstract】 Objective To assess the prognostic value of thyroxin combined with B-type natriuretic peptide(BNP) in patients with acute heart failure(AHF). Methods A total of 619 AHF patients were included in this study. Thyroid hormone profile, BNP were measured within 24 h after admission. The patients were divided into survival group and non-survival group. Using Cox hazards model, receiver operating characteristic curve and Kaplan-Meier survival analysis, the correlation of thyroid hormone levels and BNP with all-cause mortalities of patients was assessed. Results The incidence of low triiodothyronine syndrome(LT3S) in patients with AHF was 44.4%. At the median follow-up time of 19±13 months, 204 patients(32.9%) were died. Multivariate Cox regression analysis showed that age(HR=1.033, 95%CI:1.017-1.049, P<0.01), FT3(HR=0.489, 95%CI:0.384-0.628, P<0.01), BNP(HR=2.136, 95% CI:1.114-4.126, P<0.01) and serum creatinine(HR=1.002, 95% CI: 1.001-1.003, P <0.05) were independent predictors for all-cause mortality. Based on the cut-off value of FT3(≤2.72pmol/L) and BNP(>2 230 pg/ml), Kaplan-Meier analysis provided the significant prognostic information with the highest risk of all-cause death(HR=7.247, 95%CI: 3.993-13.152, P<0.01) in the low FT3(≤2.72 pmol/L)/high BNP(>2 230pg/ml) group. Conclusion FT3 levels appear to be independent predictor for all-cause mortalities among AHF patients, and low FT3 and high BNP levels predicts a worse long-term outcome.

【基金】 绍兴市卫生计生科技计划项目(2016CX027)
  • 【文献出处】 浙江医学 ,Zhejiang Medical Journal , 编辑部邮箱 ,2017年17期
  • 【分类号】R541.6
  • 【被引频次】1
  • 【下载频次】39
节点文献中: 

本文链接的文献网络图示:

本文的引文网络